CSBR:NASDAQ
Champions Oncology Inc
$4.53
arrow_downward
-1.34%(-0.062) 1D
Nov 18, 3:22:19 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.55
High
$4.60
Low
$4.41
Mkt. cap
63.07M
Avg. vol.
7.41K
Volume
10.86K
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.55
High
$4.60
Low
$4.41
Mkt. cap
63.07M
Avg. vol.
7.41K
Volume
10.86K
52-wk high
$8.31
52-wk low
$4.41
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%
FOREX.com
·
6 minutes ago
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
BigGo Finance
·
1 hour ago
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
Traders Union
·
1 hour ago
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com